Explore comprehensive CDMO services offered by Dipharma, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. Dipharma enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China, Italy, U.S.A.
Description: Dipharma is a global pharmaceutical group with two main branches: a Swiss company specializing in generic drugs for rare inborn metabolic diseases, and an Italian-based CDMO (Contract Development and Manufacturing Organization) that produces Active Pharmaceutical Ingredients (APIs), new chemical entities (NCEs), and advanced intermediates for the pharmaceutical industry. Founded in 1949, the family-owned group has grown into a global presence with facilities in Italy and the USA, and commercial offices in several countries.
